MedTrace Logo

OneDoc Picopulse™ for the Treatment of Melasma Among Malaysian Women

NCT04834167 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2023-11-30

No results posted yet for this study

Summary

OneDoc Picopulse™ is a radiopulse technology beauty grade device invented for treating melasma.

Conditions

  • Skin Diseases
  • Skin Disorder
  • Melanoma (Skin)

Interventions

DEVICE

OneDoc Picopulse

Eligible patients will proceed to receive skin cleansing prior to OneDoc Picopulse treatment. After the cleansing, the patients will receive OneDoc Picopulse treatment for 15 mins. Patients will receive ten picopulse treatments for bi-monthly.

Sponsors & Collaborators

  • Universiti Tunku Abdul Rahman

    lead OTHER

Principal Investigators

  • Yang Mooi Lim, PhD · Universiti Tunku Abdul Rahman

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2022-12-01
Completion
2022-12-01

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04834167 on ClinicalTrials.gov